Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Charles Duncan is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 08/14/2025
Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
04/02/2025 | ITCI | Intra-Cellular Therapies | — | — | $132 → $132 | Reiterates | Neutral → Neutral | |||
03/28/2025 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | Overweight → Overweight | |||
02/27/2025 | ACAD | ACADIA Pharmaceuticals | $25.13 | 11.42% | $28 → $28 | Reiterates | Overweight → Overweight | |||
02/26/2025 | JAZZ | Jazz Pharmaceuticals | $117.12 | 28.07% | $140 → $150 | Downgrade | Overweight → Neutral | |||
02/19/2025 | AXSM | Axsome Therapeutics | $109.00 | 40.37% | $153 → $153 | Reiterates | Overweight → Overweight | |||
02/13/2025 | GHRS | GH Research | $12.81 | 9.29% | → $14 | Initiates | → Overweight | |||
01/10/2025 | DRUG | Bright Minds Biosciences | $43.11 | — | — | Initiates | → Overweight | |||
12/17/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | Overweight → Overweight | |||
12/12/2024 | AXSM | Axsome Therapeutics | $109.00 | 11.01% | $121 → $121 | Reiterates | Overweight → Overweight | |||
12/10/2024 | STOK | Stoke Therapeutics | $16.91 | — | — | Reiterates | Overweight → Overweight | |||
11/14/2024 | MRNS | Marinus Pharma | — | — | $4 → $4 | Reiterates | Overweight → Overweight | |||
10/30/2024 | HRMY | Harmony Biosciences | $36.67 | 58.17% | $51 → $58 | Maintains | Overweight | |||
10/25/2024 | MRNS | Marinus Pharma | — | — | $13 → $4 | Maintains | Overweight | |||
10/25/2024 | ALKS | Alkermes | $28.82 | 49.2% | $48 → $43 | Maintains | Overweight | |||
10/23/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
10/18/2024 | CYTK | Cytokinetics | $36.88 | — | — | Reiterates | → Overweight | |||
10/10/2024 | ALKS | Alkermes | $28.82 | 66.55% | $48 → $48 | Reiterates | Overweight → Overweight | |||
10/04/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
09/30/2024 | PRTA | Prothena Corp | $8.05 | — | — | Reiterates | → Overweight | |||
09/24/2024 | MRNS | Marinus Pharma | — | — | $13 → $13 | Reiterates | Overweight → Overweight | |||
09/24/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
09/20/2024 | ITCI | Intra-Cellular Therapies | — | — | $130 → $130 | Reiterates | Overweight → Overweight | |||
09/20/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
09/16/2024 | NBIX | Neurocrine Biosciences | $131.62 | 17.76% | $155 → $155 | Reiterates | Overweight → Overweight | |||
09/16/2024 | MRNS | Marinus Pharma | — | — | $13 → $13 | Reiterates | Overweight → Overweight | |||
09/16/2024 | ITCI | Intra-Cellular Therapies | — | — | $130 → $130 | Reiterates | Overweight → Overweight | |||
09/16/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
09/16/2024 | ALKS | Alkermes | $28.82 | 66.55% | $48 → $48 | Reiterates | Overweight → Overweight | |||
09/09/2024 | KALV | KalVista Pharma | $12.59 | — | — | Reiterates | → Overweight | |||
09/09/2024 | CYTK | Cytokinetics | $36.88 | — | — | Reiterates | → Overweight | |||
09/09/2024 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | → Overweight | |||
09/09/2024 | MRNS | Marinus Pharma | — | — | $13 → $13 | Reiterates | Overweight → Overweight | |||
09/09/2024 | JAZZ | Jazz Pharmaceuticals | $117.12 | 19.54% | $140 → $140 | Reiterates | Overweight → Overweight | |||
09/09/2024 | DNLI | Denali Therapeutics | $14.55 | 140.55% | $35 → $35 | Reiterates | Overweight → Overweight | |||
09/09/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
09/06/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
09/06/2024 | ITCI | Intra-Cellular Therapies | — | — | $68 → $92 | Upgrade | Neutral → Overweight | |||
08/29/2024 | NBIX | Neurocrine Biosciences | $131.62 | 17.76% | $170 → $155 | Maintains | Overweight | |||
08/19/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
08/12/2024 | PRTA | Prothena Corp | $8.05 | — | — | Reiterates | → Overweight | |||
08/12/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
08/08/2024 | ITCI | Intra-Cellular Therapies | — | — | $120 → $130 | Maintains | Overweight | |||
08/07/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 11.42% | $37 → $28 | Maintains | Overweight | |||
08/01/2024 | VNDA | Vanda Pharma | $4.50 | 188.89% | $11 → $13 | Maintains | Overweight | |||
08/01/2024 | JAZZ | Jazz Pharmaceuticals | $117.12 | 19.54% | $140 → $140 | Reiterates | Overweight → Overweight | |||
07/31/2024 | CYBN | Cybin | — | — | — | Reiterates | → Overweight | |||
07/30/2024 | CGTX | Cognition Therapeutics | $1.22 | — | — | Downgrade | Overweight → Neutral | |||
07/26/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
07/25/2024 | NBIX | Neurocrine Biosciences | $131.62 | 17.76% | $155 → $155 | Reiterates | Overweight → Overweight | |||
07/25/2024 | ALKS | Alkermes | $28.82 | 66.55% | $48 → $48 | Reiterates | Overweight → Overweight | |||
07/11/2024 | VNDA | Vanda Pharma | $4.50 | 144.44% | → $11 | Initiates | → Overweight | |||
06/21/2024 | MNMD | Mind Medicine | $10.00 | — | — | Reiterates | → Overweight | |||
06/21/2024 | CYBN | Cybin | — | — | — | Reiterates | → Overweight | |||
06/21/2024 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | → Overweight | |||
06/21/2024 | ATAI | ATAI Life Sciences | $4.05 | — | — | Reiterates | → Overweight | |||
06/14/2024 | ITCI | Intra-Cellular Therapies | — | — | $120 → $120 | Reiterates | Overweight → Overweight | |||
05/30/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
05/23/2024 | ALKS | Alkermes | $28.82 | 66.55% | $43 → $48 | Maintains | Overweight | |||
05/09/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 47.23% | $37 → $37 | Reiterates | Overweight → Overweight | |||
04/30/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 47.23% | $37 → $37 | Reiterates | Overweight → Overweight | |||
04/30/2024 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | → Overweight | |||
04/24/2024 | ITCI | Intra-Cellular Therapies | — | — | $120 → $120 | Reiterates | Overweight → Overweight | |||
04/19/2024 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | → Overweight | |||
04/18/2024 | CMPS | Compass Pathways | $4.40 | — | — | Reiterates | → Overweight | |||
04/18/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
04/12/2024 | HRMY | Harmony Biosciences | $36.67 | 33.62% | $49 → $49 | Reiterates | Overweight → Overweight | |||
04/10/2024 | AXSM | Axsome Therapeutics | $109.00 | -1.83% | $107 → $107 | Reiterates | Overweight → Overweight | |||
04/10/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 47.23% | $37 → $37 | Reiterates | Overweight → Overweight | |||
04/10/2024 | MRNS | Marinus Pharma | — | — | $28 → $28 | Reiterates | Overweight → Overweight | |||
04/10/2024 | JAZZ | Jazz Pharmaceuticals | $117.12 | 53.69% | $180 → $180 | Reiterates | Overweight → Overweight | |||
04/10/2024 | BHVN | Biohaven | $14.45 | — | — | Reiterates | → Overweight | |||
04/10/2024 | PRTA | Prothena Corp | $8.05 | — | — | Reiterates | → Overweight | |||
04/10/2024 | NBIX | Neurocrine Biosciences | $131.62 | 17.76% | → $155 | Reiterates | Overweight → Overweight | |||
04/04/2024 | ATAI | ATAI Life Sciences | $4.05 | — | — | Reiterates | → Overweight | |||
04/04/2024 | STOK | Stoke Therapeutics | $16.91 | — | — | Reiterates | → Overweight | |||
03/28/2024 | HRMY | Harmony Biosciences | $36.67 | 33.62% | $49 → $49 | Reiterates | Overweight → Overweight | |||
03/22/2024 | CPRX | Catalyst Pharmaceuticals | $20.70 | 64.25% | $34 → $34 | Reiterates | Overweight → Overweight | |||
03/22/2024 | JAZZ | Jazz Pharmaceuticals | $117.12 | 53.69% | $180 → $180 | Reiterates | Overweight → Overweight | |||
03/14/2024 | CPRX | Catalyst Pharmaceuticals | $20.70 | 64.25% | $34 → $34 | Reiterates | Overweight → Overweight | |||
03/12/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 47.23% | $42 → $37 | Maintains | Overweight | |||
03/01/2024 | CPRX | Catalyst Pharmaceuticals | $20.70 | 64.25% | $27 → $34 | Maintains | Overweight | |||
02/29/2024 | JAZZ | Jazz Pharmaceuticals | $117.12 | 53.69% | $180 → $180 | Reiterates | Overweight → Overweight | |||
02/28/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 67.13% | $42 → $42 | Reiterates | Overweight → Overweight | |||
02/23/2024 | HRMY | Harmony Biosciences | $36.67 | 33.62% | $49 → $49 | Reiterates | Overweight → Overweight | |||
02/23/2024 | ITCI | Intra-Cellular Therapies | — | — | $101 → $101 | Reiterates | Overweight → Overweight | |||
02/21/2024 | AXSM | Axsome Therapeutics | $109.00 | -5.5% | $108 → $103 | Maintains | Overweight | |||
02/20/2024 | KRTX | Karuna Therapeutics | — | — | $330 → $330 | Reiterates | Neutral → Neutral | |||
02/20/2024 | AXSM | Axsome Therapeutics | $109.00 | -0.92% | → $108 | Reiterates | Overweight → Overweight | |||
02/02/2024 | ACAD | ACADIA Pharmaceuticals | $25.13 | 67.13% | $42 → $42 | Reiterates | Overweight → Overweight | |||
01/22/2024 | AXSM | Axsome Therapeutics | $109.00 | -0.92% | $108 → $108 | Reiterates | Overweight → Overweight | |||
01/17/2024 | KRTX | Karuna Therapeutics | — | — | $330 → $330 | Reiterates | Neutral → Neutral | |||
01/09/2024 | PRTA | Prothena Corp | $8.05 | 980.75% | $129 → $87 | Maintains | Overweight | |||
12/20/2023 | AXSM | Axsome Therapeutics | $109.00 | -0.92% | $108 → $108 | Reiterates | Overweight → Overweight | |||
12/18/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | $129 → $129 | Reiterates | Overweight → Overweight | |||
12/14/2023 | ACAD | ACADIA Pharmaceuticals | $25.13 | 67.13% | $42 → $42 | Reiterates | Overweight → Overweight | |||
12/14/2023 | ITCI | Intra-Cellular Therapies | — | — | $101 → $101 | Reiterates | Overweight → Overweight | |||
12/07/2023 | CERE | Cerevel Therapeutics Hldg | — | — | $38 → $45 | Downgrade | Overweight → Neutral | |||
11/07/2023 | AXSM | Axsome Therapeutics | $109.00 | -0.92% | → $108 | Reiterates | Overweight → Overweight | |||
11/03/2023 | ITCI | Intra-Cellular Therapies | — | — | $98 → $101 | Maintains | Overweight | |||
10/24/2023 | DNLI | Denali Therapeutics | $14.55 | 140.55% | $85 → $35 | Assumes | → Overweight | |||
10/24/2023 | CRNX | Crinetics Pharmaceuticals | $30.10 | 66.11% | $52 → $50 | Assumes | → Overweight | |||
10/24/2023 | NBIX | Neurocrine Biosciences | $131.62 | — | — | Assumes | → Overweight | |||
10/23/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
10/09/2023 | CYTK | Cytokinetics | $36.88 | 76.25% | $59 → $65 | Maintains | Overweight | |||
09/22/2023 | SLDB | Solid Biosciences | $6.68 | -25.15% | → $5 | Initiates | → Overweight | |||
09/21/2023 | MRNS | Marinus Pharma | — | — | → $28 | Reiterates | Overweight → Overweight | |||
09/21/2023 | SEEL | Seelos Therapeutics | $0.53 | — | — | Downgrade | Overweight → Neutral | |||
09/13/2023 | NBIX | Neurocrine Biosciences | $131.62 | 3.33% | → $136 | Reiterates | Overweight → Overweight | |||
09/07/2023 | VXRT | Vaxart | $0.39 | 913.43% | → $4 | Reiterates | Overweight → Overweight | |||
08/31/2023 | DNLI | Denali Therapeutics | $14.55 | 484.19% | → $85 | Reiterates | Overweight → Overweight | |||
08/29/2023 | CYBN | Cybin | — | — | → $3 | Reiterates | Overweight → Overweight | |||
08/22/2023 | LUCD | Lucid Diagnostics | $0.99 | 304.04% | → $4 | Reiterates | Overweight → Overweight | |||
08/22/2023 | XENE | Xenon Pharmaceuticals | $37.57 | 54.38% | → $58 | Reiterates | Overweight → Overweight | |||
08/22/2023 | SEEL | Seelos Therapeutics | $0.53 | 278% | → $2 | Reiterates | Overweight → Overweight | |||
08/22/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
08/22/2023 | NBIX | Neurocrine Biosciences | $131.62 | 3.33% | → $136 | Reiterates | Overweight → Overweight | |||
08/22/2023 | MNMD | Mind Medicine | $10.00 | -30% | → $7 | Reiterates | Overweight → Overweight | |||
08/22/2023 | LUMO | Lumos Pharma | — | — | → $10 | Reiterates | Overweight → Overweight | |||
08/22/2023 | KRTX | Karuna Therapeutics | — | — | → $214 | Reiterates | Neutral → Neutral | |||
08/22/2023 | KALV | KalVista Pharma | $12.59 | 58.86% | → $20 | Reiterates | Overweight → Overweight | |||
08/22/2023 | ITCI | Intra-Cellular Therapies | — | — | → $98 | Reiterates | Overweight → Overweight | |||
08/22/2023 | HRMY | Harmony Biosciences | $36.67 | 104.53% | → $75 | Reiterates | Overweight → Overweight | |||
08/22/2023 | DNLI | Denali Therapeutics | $14.55 | 484.19% | → $85 | Reiterates | Overweight → Overweight | |||
08/22/2023 | CYTK | Cytokinetics | $36.88 | 59.98% | → $59 | Reiterates | Overweight → Overweight | |||
08/22/2023 | CYBN | Cybin | — | — | → $3 | Reiterates | Overweight → Overweight | |||
08/22/2023 | CRNX | Crinetics Pharmaceuticals | $30.10 | 49.5% | → $45 | Reiterates | Overweight → Overweight | |||
08/22/2023 | CPRX | Catalyst Pharmaceuticals | $20.70 | 30.43% | → $27 | Reiterates | Overweight → Overweight | |||
08/22/2023 | BIVI | BioVie | $1.75 | 528.61% | → $11 | Reiterates | Overweight → Overweight | |||
08/22/2023 | AXSM | Axsome Therapeutics | $109.00 | -0.92% | → $108 | Reiterates | Overweight → Overweight | |||
08/16/2023 | LUCD | Lucid Diagnostics | $0.99 | 304.04% | → $4 | Reiterates | Overweight → Overweight | |||
08/16/2023 | CLNN | Clene | $3.80 | 5.29% | → $4 | Reiterates | Overweight → Overweight | |||
08/15/2023 | SEEL | Seelos Therapeutics | $0.53 | 278% | → $2 | Reiterates | Overweight → Overweight | |||
08/15/2023 | RETA | Reata Pharmaceuticals | — | — | → $172 | Reiterates | Neutral → Neutral | |||
08/15/2023 | LUMO | Lumos Pharma | — | — | $14 → $10 | Maintains | Overweight | |||
08/14/2023 | CRDL | Cardiol Therapeutics | $1.14 | 163.16% | → $3 | Reiterates | Overweight → Overweight | |||
08/11/2023 | CPRX | Catalyst Pharmaceuticals | $20.70 | 30.43% | $25 → $27 | Maintains | Overweight | |||
08/10/2023 | DNLI | Denali Therapeutics | $14.55 | 484.19% | → $85 | Reiterates | Overweight → Overweight | |||
08/08/2023 | STOK | Stoke Therapeutics | $16.91 | -17.21% | $18 → $14 | Maintains | Overweight | |||
08/07/2023 | VXRT | Vaxart | $0.39 | 913.43% | $6 → $4 | Maintains | Overweight | |||
07/24/2023 | LUMO | Lumos Pharma | — | — | → $14 | Reiterates | Overweight → Overweight | |||
07/24/2023 | RETA | Reata Pharmaceuticals | — | — | $110 → $145 | Maintains | Overweight | |||
07/18/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
07/18/2023 | BIVI | BioVie | $1.75 | 528.61% | → $11 | Reiterates | Overweight → Overweight | |||
07/17/2023 | BHVN | Biohaven | $14.45 | 114.53% | → $31 | Reiterates | Overweight → Overweight | |||
07/11/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
06/28/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
06/28/2023 | RETA | Reata Pharmaceuticals | — | — | → $110 | Reiterates | Overweight → Overweight | |||
06/28/2023 | CYBN | Cybin | — | — | → $3 | Reiterates | Overweight → Overweight | |||
06/23/2023 | MRNS | Marinus Pharma | — | — | $28 → $28 | Reiterates | Overweight → Overweight | |||
06/23/2023 | ITCI | Intra-Cellular Therapies | — | — | $90 → $90 | Reiterates | Overweight → Overweight | |||
06/23/2023 | HRMY | Harmony Biosciences | $36.67 | 104.53% | $75 → $75 | Reiterates | Overweight → Overweight | |||
06/23/2023 | SEEL | Seelos Therapeutics | $0.53 | 278% | → $2 | Reiterates | Overweight → Overweight | |||
06/22/2023 | DNLI | Denali Therapeutics | $14.55 | 484.19% | → $85 | Reiterates | Overweight → Overweight | |||
06/22/2023 | CRNX | Crinetics Pharmaceuticals | $30.10 | 49.5% | → $45 | Reiterates | Overweight → Overweight | |||
06/22/2023 | AXSM | Axsome Therapeutics | $109.00 | -4.59% | → $104 | Reiterates | Overweight → Overweight | |||
06/21/2023 | XENE | Xenon Pharmaceuticals | $37.57 | 54.38% | → $58 | Reiterates | Overweight → Overweight | |||
06/21/2023 | PRTA | Prothena Corp | $8.05 | 1502.48% | → $129 | Reiterates | Overweight → Overweight | |||
06/21/2023 | CPRX | Catalyst Pharmaceuticals | $20.70 | 20.77% | → $25 | Reiterates | Overweight → Overweight | |||
05/23/2023 | STOK | Stoke Therapeutics | $16.91 | 47.84% | $20 → $25 | Maintains | Overweight | |||
05/18/2023 | MNMD | Mind Medicine | $10.00 | -30% | → $7 | Reiterates | → Overweight | |||
05/17/2023 | BIVI | BioVie | $1.75 | 528.61% | → $11 | Reiterates | Overweight → Overweight | |||
05/17/2023 | LUCD | Lucid Diagnostics | $0.99 | 304.04% | $4.5 → $4 | Maintains | Overweight | |||
05/16/2023 | CLNN | Clene | $3.80 | 5.29% | $5 → $4 | Maintains | Buy | |||
05/16/2023 | SEEL | Seelos Therapeutics | $0.53 | 278% | $3 → $2 | Maintains | Overweight | |||
05/09/2023 | AXSM | Axsome Therapeutics | $109.00 | -4.59% | → $104 | Reiterates | → Overweight | |||
05/08/2023 | PRTA | Prothena Corp | $8.05 | 1390.68% | $98 → $120 | Maintains | Overweight | |||
05/05/2023 | ITCI | Intra-Cellular Therapies | — | — | $87 → $90 | Maintains | Overweight | |||
05/03/2023 | HRMY | Harmony Biosciences | $36.67 | 104.53% | $71 → $75 | Maintains | Overweight | |||
04/25/2023 | XENE | Xenon Pharmaceuticals | $37.57 | 54.38% | → $58 | Initiates | → Overweight | |||
04/04/2023 | BHVN | Biohaven | $14.45 | 114.53% | $27 → $31 | Maintains | Overweight | |||
04/03/2023 | CYTK | Cytokinetics | $36.88 | 59.98% | $61 → $59 | Maintains | Overweight | |||
03/29/2023 | ITCI | Intra-Cellular Therapies | — | — | $83 → $87 | Maintains | Overweight | |||
03/27/2023 | RETA | Reata Pharmaceuticals | — | — | $121 → $138 | Maintains | Overweight | |||
03/14/2023 | ACAD | ACADIA Pharmaceuticals | $25.13 | 31.32% | $28 → $33 | Maintains | Overweight | |||
03/10/2023 | KALV | KalVista Pharma | $12.59 | 162.11% | $49 → $33 | Maintains | Overweight | |||
03/10/2023 | CLNN | Clene | $3.80 | 110.59% | $6 → $8 | Maintains | Buy | |||
03/08/2023 | MRNS | Marinus Pharma | — | — | → $28 | Reiterates | → Overweight | |||
03/08/2023 | KRTX | Karuna Therapeutics | — | — | → $214 | Initiates | → Neutral | |||
03/07/2023 | CYTK | Cytokinetics | $36.88 | 65.4% | → $61 | Reiterates | → Overweight | |||
03/07/2023 | STOK | Stoke Therapeutics | $16.91 | 18.27% | → $20 | Reiterates | → Overweight | |||
03/01/2023 | RETA | Reata Pharmaceuticals | — | — | $61 → $121 | Maintains | Overweight | |||
02/07/2023 | NBIX | Neurocrine Biosciences | $131.62 | -3.51% | $132 → $127 | Reiterates | → Overweight | |||
02/01/2023 | ITCI | Intra-Cellular Therapies | — | — | → $83 | Reiterates | → Overweight | |||
12/21/2022 | PRTA | Prothena Corp | $8.05 | 1117.39% | $91 → $98 | Maintains | Overweight | |||
12/06/2022 | AVXL | Anavex Life Sciences | $10.77 | 2.15% | $16 → $11 | Downgrade | Overweight → Neutral | |||
11/22/2022 | FENC | Fennec Pharmaceuticals | $9.25 | 29.73% | $9 → $12 | Upgrade | Neutral → Overweight | |||
11/02/2022 | NBIX | Neurocrine Biosciences | $131.62 | 0.29% | $127 → $132 | Maintains | Overweight | |||
09/29/2022 | CGTX | Cognition Therapeutics | $1.22 | 883.36% | → $12 | Initiates | → Overweight | |||
09/29/2022 | CERE | Cerevel Therapeutics Hldg | — | — | → $41 | Initiates | → Overweight | |||
09/02/2022 | VXRT | Vaxart | $0.39 | 1926.86% | $11 → $8 | Maintains | Overweight | |||
07/22/2022 | BIVI | BioVie | $1.75 | 300.02% | → $7 | Initiates | → Overweight | |||
06/29/2022 | AXSM | Axsome Therapeutics | $109.00 | -41.28% | $47 → $64 | Maintains | Overweight | |||
06/21/2022 | ACAD | ACADIA Pharmaceuticals | $25.13 | 3.46% | $37 → $26 | Maintains | Overweight | |||
06/08/2022 | NVAX | Novavax | $8.81 | 1806.88% | $146 → $168 | Maintains | Overweight | |||
05/26/2022 | STOK | Stoke Therapeutics | $16.91 | 124.72% | $68 → $38 | Maintains | Overweight | |||
04/22/2022 | ITCI | Intra-Cellular Therapies | — | — | → $59 | Initiates | → Neutral | |||
04/14/2022 | HRMY | Harmony Biosciences | $36.67 | 71.8% | → $63 | Initiates | → Overweight | |||
04/11/2022 | CLNN | Clene | $3.80 | 163.23% | → $10 | Maintains | Overweight | |||
04/08/2022 | APTX | Aptinyx | — | — | $11 → $5 | Maintains | Overweight | |||
03/10/2022 | ACAD | ACADIA Pharmaceuticals | $25.13 | 47.23% | $32 → $37 | Maintains | Overweight | |||
03/08/2022 | SEEL | Seelos Therapeutics | $0.53 | 467% | $5 → $3 | Maintains | Overweight | |||
02/18/2022 | ORMP | Oramed Pharmaceuticals | $2.16 | 825.93% | → $20 | Initiates | → Overweight | |||
02/18/2022 | VTVT | vTv Therapeutics | $14.60 | -65.75% | → $5 | Initiates | → Overweight | |||
01/10/2022 | BNOX | Bionomics | — | — | → $52 | Initiates | → Overweight | |||
12/17/2021 | CRDL | Cardiol Therapeutics | $1.14 | 601.75% | → $8 | Initiates | → Overweight | |||
12/09/2021 | RETA | Reata Pharmaceuticals | — | — | $112 → $68 | Maintains | Overweight | |||
11/08/2021 | LUCD | Lucid Diagnostics | $0.99 | 2021.21% | → $21 | Initiates | → Overweight | |||
11/02/2021 | VXRT | Vaxart | $0.39 | 3700.35% | → $15 | Initiates | → Overweight | |||
09/17/2021 | PRTA | Prothena Corp | $8.05 | 1179.5% | $70 → $103 | Maintains | Overweight | |||
09/13/2021 | BHVN | Biohaven | $14.45 | 1041.88% | $151 → $165 | Maintains | Overweight | |||
08/26/2021 | CYBN | Cybin | — | — | → $9 | Initiates | → Overweight | |||
07/13/2021 | ATAI | ATAI Life Sciences | $4.05 | 1011.11% | → $45 | Initiates | → Overweight | |||
06/15/2021 | NVAX | Novavax | $8.81 | 2987.33% | $217 → $272 | Maintains | Overweight | |||
06/01/2021 | SEEL | Seelos Therapeutics | $0.53 | 1790% | → $10 | Initiates | → Overweight | |||
06/01/2021 | BHVN | Biohaven | $14.45 | 868.86% | $125 → $140 | Maintains | Overweight | |||
05/12/2021 | NVAX | Novavax | $8.81 | 2363.05% | $338 → $217 | Maintains | Overweight | |||
05/03/2021 | CLNN | Clene | $3.80 | 479.12% | → $22 | Initiates | → Overweight | |||
04/20/2021 | OVID | Ovid Therapeutics | $0.79 | 406.46% | $8 → $4 | Downgrade | Overweight → Neutral | |||
02/23/2021 | AVXL | Anavex Life Sciences | $10.77 | 132.16% | $10 → $25 | Reiterates | → Overweight | |||
02/05/2021 | NVAX | Novavax | $8.81 | 3736.46% | $248 → $338 | Maintains | Overweight | |||
12/03/2020 | LUMO | Lumos Pharma | — | — | → $32 | Initiates | → Overweight | |||
10/28/2020 | APTX | Aptinyx | — | — | $9 → $12 | Maintains | Overweight | |||
10/23/2020 | STOK | Stoke Therapeutics | $16.91 | 189.77% | → $49 | Initiates | → Overweight | |||
10/23/2020 | SAVA | Cassava Sciences | $2.28 | 952.59% | → $24 | Initiates | → Overweight | |||
10/21/2020 | PRTA | Prothena Corp | $8.05 | 198.14% | $20 → $24 | Maintains | Overweight | |||
09/28/2020 | INO | Inovio Pharmaceuticals | $1.69 | 610.06% | $31 → $12 | Downgrade | Overweight → Neutral | |||
09/11/2020 | PRVL | Prevail Therapeutics | — | — | → $26 | Initiates | → Overweight | |||
09/01/2020 | AIMT | Aimmune Therapeutics | — | — | $24 → $35 | Downgrade | Overweight → Neutral | |||
07/21/2020 | ACAD | ACADIA Pharmaceuticals | $25.13 | 142.74% | $63 → $61 | Maintains | Overweight | |||
06/26/2020 | INO | Inovio Pharmaceuticals | $1.69 | 2562.72% | $17 → $45 | Maintains | Overweight | |||
06/19/2020 | NVAX | Novavax | $8.81 | 898.84% | $45 → $88 | Maintains | Overweight | |||
06/18/2020 | OVID | Ovid Therapeutics | $0.79 | 1545.99% | $7 → $13 | Maintains | Overweight | |||
06/05/2020 | FENC | Fennec Pharmaceuticals | $9.25 | 94.59% | → $18 | Initiates | → Overweight | |||
06/01/2020 | GERN | Geron | $1.40 | 185.71% | $3 → $4 | Maintains | Overweight | |||
05/19/2020 | CARA | Cara Therapeutics | — | — | $34 → $40 | Reiterates | → Overweight | |||
05/18/2020 | RETA | Reata Pharmaceuticals | — | — | $270 → $275 | Maintains | Overweight | |||
05/11/2020 | BHVN | Biohaven | $14.45 | 467.48% | $75 → $82 | Maintains | Overweight | |||
05/08/2020 | ACAD | ACADIA Pharmaceuticals | $25.13 | 150.7% | $58 → $63 | Reiterates | → Overweight | |||
05/04/2020 | HALO | Halozyme Therapeutics | $64.50 | -39.53% | $35 → $39 | Reiterates | → Overweight | |||
04/28/2020 | AXSM | Axsome Therapeutics | $109.00 | 20.18% | $125 → $131 | Maintains | Overweight | |||
04/22/2020 | CARA | Cara Therapeutics | — | — | $26 → $34 | Reiterates | → Overweight | |||
04/17/2020 | CYTK | Cytokinetics | $36.88 | -37.64% | $12 → $23 | Reiterates | → Overweight | |||
04/15/2020 | INO | Inovio Pharmaceuticals | $1.69 | 669.23% | $12 → $13 | Maintains | Overweight | |||
03/23/2020 | AIMT | Aimmune Therapeutics | — | — | $64 → $32 | Maintains | Overweight | |||
03/17/2020 | NVAX | Novavax | $8.81 | 81.61% | $6 → $16 | Upgrade | Neutral → Overweight | |||
02/27/2020 | ACAD | ACADIA Pharmaceuticals | $25.13 | 198.45% | $70 → $75 | Reiterates | → Overweight | |||
02/21/2020 | CORT | Corcept Therapeutics | $72.80 | -79.4% | $14 → $15 | Reiterates | → Neutral | |||
02/20/2020 | RETA | Reata Pharmaceuticals | — | — | $314 → $320 | Reiterates | → Overweight | |||
02/18/2020 | ITCI | Intra-Cellular Therapies | — | — | $43 → $47 | Reiterates | → Overweight | |||
02/14/2020 | CPRX | Catalyst Pharmaceuticals | $20.70 | -42.03% | $11 → $12 | Reiterates | → Overweight | |||
02/03/2020 | AIMT | Aimmune Therapeutics | — | — | $55 → $64 | Maintains | Overweight | |||
01/27/2020 | HALO | Halozyme Therapeutics | $64.50 | -45.74% | $27 → $35 | Maintains | Overweight | |||
12/30/2019 | AXSM | Axsome Therapeutics | $109.00 | 14.68% | $104 → $125 | Reiterates | → Overweight | |||
12/17/2019 | ADMS | Adamas Pharmaceuticals | — | — | $8 → $7 | Reiterates | → Neutral | |||
12/16/2019 | AXSM | Axsome Therapeutics | $109.00 | -4.59% | $55 → $104 | Maintains | Overweight | |||
11/26/2019 | ACAD | ACADIA Pharmaceuticals | $25.13 | 178.55% | $63 → $70 | Reiterates | → Overweight | |||
11/20/2019 | HALO | Halozyme Therapeutics | $64.50 | -58.14% | $26 → $27 | Reiterates | → Overweight | |||
11/20/2019 | RETA | Reata Pharmaceuticals | — | — | $250 → $314 | Reiterates | → Overweight | |||
11/04/2019 | RETA | Reata Pharmaceuticals | — | — | $180 → $250 | Maintains | Overweight | |||
10/15/2019 | RETA | Reata Pharmaceuticals | — | — | $125 → $180 | Maintains | Overweight | |||
09/23/2019 | ACAD | ACADIA Pharmaceuticals | $25.13 | 122.84% | $49 → $56 | Maintains | Overweight | |||
09/09/2019 | ADMS | Adamas Pharmaceuticals | — | — | → $8 | Initiates | → Neutral | |||
08/27/2019 | ACAD | ACADIA Pharmaceuticals | $25.13 | 59.17% | $30 → $40 | Reiterates | → Overweight | |||
08/15/2019 | GERN | Geron | $1.40 | 185.71% | → $4 | Initiates | → Overweight | |||
03/26/2019 | INO | Inovio Pharmaceuticals | $1.69 | — | — | Initiates | → Overweight | |||
03/22/2019 | APTX | Aptinyx | — | — | $18 → $12 | Maintains | Overweight | |||
03/21/2019 | AXSM | Axsome Therapeutics | $109.00 | -77.06% | $16 → $25 | Maintains | Overweight | |||
02/06/2019 | VNDA | Vanda Pharma | $4.50 | — | — | Downgrade | Overweight → Neutral | |||
02/01/2019 | CORT | Corcept Therapeutics | $72.80 | -80.77% | $20 → $14 | Downgrade | Overweight → Neutral | |||
12/12/2018 | CORT | Corcept Therapeutics | $72.80 | -60.16% | $17 → $29 | Upgrade | Neutral → Overweight | |||
12/04/2018 | VNDA | Vanda Pharma | $4.50 | 855.56% | → $43 | Upgrade | Neutral → Overweight | |||
11/29/2018 | CPRX | Catalyst Pharmaceuticals | $20.70 | -61.35% | → $8 | Reiterates | → Overweight | |||
11/15/2018 | OVID | Ovid Therapeutics | $0.79 | — | — | Initiates | → Overweight | |||
11/15/2018 | BHVN | Biohaven | $14.45 | 280.63% | $57 → $55 | Maintains | Overweight | |||
11/15/2018 | AXSM | Axsome Therapeutics | $109.00 | -85.32% | → $16 | Reinstates | → Overweight | |||
11/15/2018 | APTX | Aptinyx | — | — | → $40 | Initiates | → Overweight | |||
11/01/2018 | ACAD | ACADIA Pharmaceuticals | $25.13 | 19.38% | $27 → $30 | Maintains | Overweight | |||
10/16/2018 | ACAD | ACADIA Pharmaceuticals | $25.13 | 7.44% | $25 → $27 | Maintains | Overweight | |||
09/21/2018 | CPRX | Catalyst Pharmaceuticals | $20.70 | -61.35% | → $8 | Initiates | → Overweight | |||
09/21/2018 | CARA | Cara Therapeutics | — | — | → $27 | Initiates | → Overweight | |||
08/23/2018 | RETA | Reata Pharmaceuticals | — | — | → $90 | Initiates | → Overweight | |||
08/23/2018 | VNDA | Vanda Pharma | $4.50 | 477.78% | → $26 | Initiates | → Neutral | |||
08/23/2018 | ITCI | Intra-Cellular Therapies | — | — | → $32 | Initiates | → Overweight | |||
08/23/2018 | CORT | Corcept Therapeutics | $72.80 | -76.65% | → $17 | Initiates | → Neutral | |||
08/23/2018 | HALO | Halozyme Therapeutics | $64.50 | -58.14% | → $27 | Initiates | → Overweight | |||
08/23/2018 | BHVN | Biohaven | $14.45 | 280.63% | → $55 | Initiates | → Overweight | |||
08/23/2018 | ACOR | Acorda Therapeutics | — | — | → $32 | Initiates | → Neutral | |||
08/23/2018 | ACAD | ACADIA Pharmaceuticals | $25.13 | -0.52% | → $25 | Initiates | → Overweight | |||
06/12/2018 | BHVN | Biohaven | $14.45 | 190.66% | → $42 | Initiates | → Overweight | |||
04/10/2018 | VTVT | vTv Therapeutics | $14.60 | — | — | Downgrade | Overweight → Neutral | |||
11/15/2017 | SGMO | Sangamo Therapeutics | $0.53 | — | — | Upgrade | Neutral → Overweight | |||
10/09/2017 | ALT | Altimmune | $3.73 | 60.86% | → $6 | Initiates | → Overweight | |||
09/29/2017 | ZYNE | Zynerba Pharmaceuticals | — | — | — | Upgrade | Neutral → Overweight | |||
06/08/2017 | INO | Inovio Pharmaceuticals | $1.69 | — | — | Upgrade | Neutral → Overweight | |||
05/01/2017 | ITCI | Intra-Cellular Therapies | — | — | $22 → $10 | Downgrade | Overweight → Neutral | |||
03/16/2017 | INO | Inovio Pharmaceuticals | $1.69 | 432.54% | $13 → $9 | Downgrade | Overweight → Neutral | |||
12/22/2016 | PDLI | PDL BioPharma | — | — | → $4 | Reinstates | → Overweight | |||
12/16/2016 | ITCI | Intra-Cellular Therapies | — | — | — | Initiates | → Overweight | |||
10/19/2016 | SGMO | Sangamo Therapeutics | $0.53 | — | — | Downgrade | Overweight → Neutral | |||
06/02/2016 | ITCI | Intra-Cellular Therapies | — | — | → $57 | Initiates | → Overweight | |||
06/01/2016 | ITCI | Intra-Cellular Therapies | — | — | → $57 | Initiates | → Overweight | |||
11/04/2015 | CARA | Cara Therapeutics | — | — | — | Initiates | → Buy | |||
08/31/2015 | ZYNE | Zynerba Pharmaceuticals | — | — | → $42 | Initiates | → Overweight | |||
08/24/2015 | VTVT | vTv Therapeutics | $14.60 | 64.38% | → $24 | Initiates | → Overweight | |||
05/14/2013 | PDLI | PDL BioPharma | — | — | → $8.5 | Initiates | → Neutral | |||
07/02/2012 | SGMO | Sangamo Therapeutics | $0.53 | 649.34% | → $4 | Downgrade | Neutral → Underweight |
